NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $178,918,516 | -1.0% | 1,756,514 | -1.9% | 0.01% | +11.1% |
| Q2 2023 | $180,715,985 | +4.6% | 1,790,863 | -4.7% | 0.01% | -10.0% |
| Q1 2023 | $172,819,332 | -49.6% | 1,878,471 | -50.3% | 0.01% | 0.0% |
| Q4 2022 | $342,623,494 | +133.9% | 3,776,714 | +96.0% | 0.01% | +11.1% |
| Q3 2022 | $146,492,000 | -12.0% | 1,927,277 | -2.2% | 0.01% | -10.0% |
| Q2 2022 | $166,516,000 | -3.3% | 1,969,905 | +0.4% | 0.01% | +11.1% |
| Q1 2022 | $172,232,000 | +0.7% | 1,962,760 | +0.4% | 0.01% | +12.5% |
| Q4 2021 | $170,978,000 | +3.7% | 1,954,700 | -3.0% | 0.01% | -11.1% |
| Q3 2021 | $164,845,000 | -11.4% | 2,015,264 | -1.2% | 0.01% | -10.0% |
| Q2 2021 | $186,083,000 | +8.5% | 2,039,489 | +1.6% | 0.01% | 0.0% |
| Q1 2021 | $171,535,000 | -10.6% | 2,006,725 | -1.3% | 0.01% | -16.7% |
| Q4 2020 | $191,908,000 | +5.0% | 2,032,291 | -3.3% | 0.01% | 0.0% |
| Q3 2020 | $182,849,000 | -1.9% | 2,102,679 | -1.5% | 0.01% | -14.3% |
| Q2 2020 | $186,405,000 | +6.8% | 2,134,244 | +0.8% | 0.01% | -6.7% |
| Q1 2020 | $174,499,000 | -16.9% | 2,116,427 | -4.6% | 0.02% | +7.1% |
| Q4 2019 | $210,066,000 | -11.2% | 2,218,465 | -18.5% | 0.01% | -22.2% |
| Q3 2019 | $236,502,000 | -3.1% | 2,721,543 | +1.8% | 0.02% | 0.0% |
| Q2 2019 | $244,079,000 | -2.5% | 2,673,208 | +2.6% | 0.02% | -10.0% |
| Q1 2019 | $250,460,000 | +11.4% | 2,605,159 | -0.6% | 0.02% | 0.0% |
| Q4 2018 | $224,890,000 | -4.1% | 2,620,787 | -3.7% | 0.02% | +11.1% |
| Q3 2018 | $234,497,000 | +12.2% | 2,721,656 | -1.7% | 0.02% | +5.9% |
| Q2 2018 | $209,076,000 | -5.9% | 2,767,754 | +0.7% | 0.02% | -10.5% |
| Q1 2018 | $222,134,000 | -7.8% | 2,747,481 | -4.3% | 0.02% | 0.0% |
| Q4 2017 | $241,040,000 | -5.9% | 2,870,906 | -3.8% | 0.02% | -13.6% |
| Q3 2017 | $256,109,000 | +0.7% | 2,983,206 | -2.1% | 0.02% | 0.0% |
| Q2 2017 | $254,273,000 | +15.0% | 3,046,276 | +2.3% | 0.02% | +10.0% |
| Q1 2017 | $221,134,000 | -1.2% | 2,977,442 | -3.1% | 0.02% | -4.8% |
| Q4 2016 | $223,905,000 | -8.5% | 3,073,951 | -0.8% | 0.02% | -16.0% |
| Q3 2016 | $244,630,000 | -6.4% | 3,098,147 | -2.2% | 0.02% | -10.7% |
| Q2 2016 | $261,289,000 | -4.6% | 3,166,717 | -16.3% | 0.03% | -6.7% |
| Q1 2016 | $274,005,000 | -22.3% | 3,782,530 | -7.8% | 0.03% | -23.1% |
| Q4 2015 | $352,793,000 | +14.7% | 4,100,356 | +22.6% | 0.04% | +8.3% |
| Q3 2015 | $307,527,000 | +22953.0% | 3,345,575 | +24557.8% | 0.04% | – |
| Q2 2015 | $1,334,000 | +9.5% | 13,568 | +9.8% | 0.00% | – |
| Q1 2015 | $1,218,000 | +6.4% | 12,357 | 0.0% | 0.00% | – |
| Q4 2014 | $1,145,000 | -1.5% | 12,357 | 0.0% | 0.00% | – |
| Q3 2014 | $1,162,000 | +3.6% | 12,357 | -0.4% | 0.00% | – |
| Q2 2014 | $1,122,000 | +5.6% | 12,410 | -0.8% | 0.00% | – |
| Q1 2014 | $1,063,000 | -44.8% | 12,511 | -53.7% | 0.00% | – |
| Q4 2013 | $1,926,000 | +99.4% | 27,049 | +114.7% | 0.00% | – |
| Q3 2013 | $966,000 | +7.0% | 12,601 | -1.3% | 0.00% | – |
| Q2 2013 | $903,000 | – | 12,761 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |